{"id":522840,"date":"2021-08-04T07:04:59","date_gmt":"2021-08-04T11:04:59","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/"},"modified":"2021-08-04T07:04:59","modified_gmt":"2021-08-04T11:04:59","slug":"fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/","title":{"rendered":"Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET"},"content":{"rendered":"<div class=\"mw_release\">\n<p>CAMBRIDGE, Mass., Aug.  04, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8FdspNNm1vl0T-rJU8qYB859J0eGH0qqYZiZIkjsRvdtEfaZfz6PoMo6fCgDdnyG8M8Pr1uRcGlrhTrnT9qF0vpyYPClYP5AlDCR9U92B3-Z-2K-7fNrhHzP2tTPV4XXyJMSCKdR06UCs5qvAuNEEVHIJ-wZetvRnUkQaOjwEStfADBZlCN-LdzOjlqRjNvHCb6weo4759kFI4t1GdMN1Xdz2sQ_RaHAIb6moNSo1CuFZIh-8u18clccL8EW0L0MEe2JfFPNtm_OTjgeNfPpLQ==\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Fulcrum Therapeutics, Inc.<\/strong><\/a>\u00a0(Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its second quarter 2021 financial results will be released on Tuesday, August 10, 2021 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.<\/p>\n<p>\n        <strong>Dial-in Number<\/strong><br \/>\n        <br \/>U.S.\/Canada Dial-in Number: 800-527-6973<br \/>International Dial-in Number: 470-495-9162<br \/>Conference ID: 3291056<\/p>\n<p>Replay Dial-in Number: 855-859-2056<br \/>Replay International Dial-in Number: 404-537-3406<br \/>Conference ID: 3291056<\/p>\n<p>An audio webcast will be accessible through the Investor Relations section of the company\u2019s website <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XL0Vb96GNnu6Pdtx3cwYMbZbvkc9fqEHYFpAAdEPpJtx8740-4sH0vb8VJZDOlgj2EkG5weBeL-wHYNUcfOAqrxQAsm3QxvZAlU3KgfXgW_jZU8l_uWltexwkgj6B7n60QzYpKuSkHB_kmp8Ob2M00vOfERwq2piy1NOJtRSD994-EnnSPF-rD5Fl4VN44IlUAmDL9PcYkQk5q_hiuisrs4UyF3oqaOzU8YIrH87qfzg4hhkIN5bl5M3XNK-QHO7zcsgV5ebkVQLpJDVXEA7nuX2743IZPiTK7Z3fDZu0ibcdgwDdr9cj78kjJG8o59rv3_YPpXGkGUEBar8T4JdYoamP8bu3tKUyAkyDZsBXFVmU6TbJOVfNCqLVr398Xhb\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.fulcrumtx.com\/events-and-presentations<\/a>. Following the live webcast, an archived replay will also be available.<\/p>\n<p>\n        <strong>About Fulcrum Therapeutics<\/strong>\u00a0<br \/>Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum\u2019s proprietary product engine identifies drug targets which can modulate gene expression to treat the known root cause of gene mis-expression. The company has advanced losmapimod to Phase 2 clinical development for the treatment of facioscapulohumeral dystrophy (FSHD). Fulcrum has also advanced FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and beta-thalassemia into Phase 1 clinical development.<\/p>\n<p>Please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NTJ-6EY_Zy2jVsXL87afk_DccZmIX2DfE00kCgUI3JYtNmsMtLKPHexMIlHtI3jQLWebrvN2EL2YFcwNjNiSMw==\" rel=\"nofollow noopener\" target=\"_blank\">www.fulcrumtx.com<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Christi Waarich<br \/>Director, Investor Relations and<br \/>Corporate Communications <br \/>617-651-8664<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NsqVDwgk9CpCNWcEFJoxrOjN1AsMkh7g6PPYJH753TG220mebOCEuN8Bs22VpLiV3zb4hH2ihazjJzyuF_UpvlATOhJDeK7cHv3Z1YaVjUw=\" rel=\"nofollow noopener\" target=\"_blank\">cwaarich@fulcrumtx.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjI0NyM0MzM5ODY2IzIxODM1NDI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/2ede4e09-e62a-4bdb-ac93-c8c23545069d\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) &#8212; Fulcrum Therapeutics, Inc.\u00a0(Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its second quarter 2021 financial results will be released on Tuesday, August 10, 2021 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments. Dial-in Number U.S.\/Canada Dial-in Number: 800-527-6973International Dial-in Number: 470-495-9162Conference ID: 3291056 Replay Dial-in Number: 855-859-2056Replay International Dial-in Number: 404-537-3406Conference ID: 3291056 An audio webcast will be accessible through the Investor Relations section of the company\u2019s website https:\/\/ir.fulcrumtx.com\/events-and-presentations. Following the live webcast, an archived replay will &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-522840","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) &#8212; Fulcrum Therapeutics, Inc.\u00a0(Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its second quarter 2021 financial results will be released on Tuesday, August 10, 2021 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments. Dial-in Number U.S.\/Canada Dial-in Number: 800-527-6973International Dial-in Number: 470-495-9162Conference ID: 3291056 Replay Dial-in Number: 855-859-2056Replay International Dial-in Number: 404-537-3406Conference ID: 3291056 An audio webcast will be accessible through the Investor Relations section of the company\u2019s website https:\/\/ir.fulcrumtx.com\/events-and-presentations. Following the live webcast, an archived replay will &hellip; Continue reading &quot;Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-04T11:04:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjI0NyM0MzM5ODY2IzIxODM1NDI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET\",\"datePublished\":\"2021-08-04T11:04:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\\\/\"},\"wordCount\":264,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjI0NyM0MzM5ODY2IzIxODM1NDI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\\\/\",\"name\":\"Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjI0NyM0MzM5ODY2IzIxODM1NDI=\",\"datePublished\":\"2021-08-04T11:04:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjI0NyM0MzM5ODY2IzIxODM1NDI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjI0NyM0MzM5ODY2IzIxODM1NDI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/","og_locale":"en_US","og_type":"article","og_title":"Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) &#8212; Fulcrum Therapeutics, Inc.\u00a0(Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its second quarter 2021 financial results will be released on Tuesday, August 10, 2021 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments. Dial-in Number U.S.\/Canada Dial-in Number: 800-527-6973International Dial-in Number: 470-495-9162Conference ID: 3291056 Replay Dial-in Number: 855-859-2056Replay International Dial-in Number: 404-537-3406Conference ID: 3291056 An audio webcast will be accessible through the Investor Relations section of the company\u2019s website https:\/\/ir.fulcrumtx.com\/events-and-presentations. Following the live webcast, an archived replay will &hellip; Continue reading \"Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-04T11:04:59+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjI0NyM0MzM5ODY2IzIxODM1NDI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET","datePublished":"2021-08-04T11:04:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/"},"wordCount":264,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjI0NyM0MzM5ODY2IzIxODM1NDI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/","name":"Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjI0NyM0MzM5ODY2IzIxODM1NDI=","datePublished":"2021-08-04T11:04:59+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjI0NyM0MzM5ODY2IzIxODM1NDI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjI0NyM0MzM5ODY2IzIxODM1NDI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on-tuesday-august-10-2021-at-800-a-m-et\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=522840"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522840\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=522840"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=522840"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=522840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}